10.1007/s11684‐019‐0683‐y
10.1016/j.lungcan.2017.07.023
10.1245/s10434‐012‐2431‐2
10.1158/1078‐0432.CCR‐17‐1341
10.1371/journal.pone.0171539
10.1016/j.jtho.2018.01.012
10.1016/j.trsl.2017.04.004
Hersom M, 2018, Companion and complementary diagnostics‐focus on PD‐L1 expression assays for PD‐1/PD‐L1 checkpoint inhibitors in non‐small cell lung cancer, Ther Drug Monit, 40, 9, 10.1097/FTD.0000000000000460
10.1007/s40291‐017‐0308‐6
10.1186/s40425‐018‐0349‐3
Gonzalez‐Cao M, 2015, Targeting PD‐1/PD‐L1 in lung cancer: current perspectives, Lung Cancer (Auckl), 6, 55
10.1186/s40880‐019‐0376‐6
10.1080/2162402X.2015.1085146
Fatima F, 2015, Stem cell‐derived exosomes: roles in stromal remodeling, tumor progression, and cancer immunotherapy, Chin J Cancer, 34, 541
10.1080/2162402X.2015.1071008
10.1016/j.chest.2016.09.030
10.1007/s00262‐017‐1958‐2
Shang N, 2017, Dendritic cells based immunotherapy, Am J Cancer Res., 7, 2091
10.1097/JTO.0b013e31821c421d
10.1016/j.cellimm.2017.12.006
10.1007/s00262‐018‐2143‐y
10.1158/0008‐5472.CAN‐13‐3118
10.1111/j.0105‐2896.2009.00879.x
10.1016/j.immuni.2017.12.014
10.1007/s12032‐008‐9142‐3
10.1016/S0065‐2776(06)93007‐7
10.1016/j.immuni.2015.04.020
10.1038/s41467‐018‐08271‐x
10.1007/s00262‐006‐0215‐x
10.1016/j.cell.2017.04.014
10.4049/jimmunol.177.11.7784
10.4049/jimmunol.182.2.963
10.1016/j.semcdb.2017.12.009
10.1016/j.ccell.2016.06.003
10.1016/j.immuni.2016.03.012
10.1080/2162402X.2016.1253655
10.1016/j.cellimm.2014.08.006
10.1016/j.semcdb.2018.02.014
10.1038/s41590‐018‐0143‐x
10.1007/s00262‐011‐1057‐8
10.1158/0008‐5472.CAN‐12‐2271
10.1080/2162402X.2015.1008355
Liu C, 2008, Plasmacytoid dendritic cells induce NK cell‐dependent, tumor antigen‐specific T cell cross‐priming and tumor regression in mice, J Clin Invest, 118, 1165
10.1158/2326‐6066.CIR‐13‐0143
10.1007/s13277‐013‐1297‐7
10.1016/j.ajpath.2015.07.009
Zhang C, 2017, The effect of semimature dendritic cell and the levels of Treg on transplantation tolerance of hepatocytes differentiated from mouse embryonic stem cell, Zhonghua Yi Xue Za Zhi, 97, 259
10.4161/21624011.2014.955331
10.1007/s00262‐016‐1820‐y
10.1158/0008‐5472.CAN‐13‐1342
10.1158/0008‐5472.CAN‐17‐1307
10.1016/j.vaccine.2017.06.041
10.1158/2159‐8290.CD‐11‐0073
10.1016/j.celrep.2016.05.085
10.1053/j.semtcvs.2016.02.008
10.1016/j.bbrc.2016.12.021
10.1016/j.lungcan.2009.01.017
10.1016/j.bbrc.2017.07.144
10.1016/j.clim.2008.09.014
10.1016/j.semcancer.2011.12.004
10.4161/21624011.2014.955684
10.1016/j.cyto.2011.01.008
Niki M, 2017, New prognostic biomarkers and therapeutic effect of bevacizumab for patients with non‐small‐cell lung cancer, Lung Cancer (Auckl), 8, 91
10.1097/PAI.0b013e3182849808
10.1007/s00005‐012‐0183‐0
10.1007/s00262‐017‐2087‐7
10.1016/j.imlet.2018.05.002
10.1080/2162402X.2018.1445457
10.1016/j.vaccine.2018.06.016
Obleukhova I, 2018, Use of antigen‐primed dendritic cells for inducing antitumor immune responses in vitro in patients with non‐small cell lung cancer, Oncol Lett, 15, 1297
10.1016/j.intimp.2017.09.014
Geskin LJ, 2018, Three antigen‐loading methods in dendritic cell vaccines for metastatic melanoma, Melanoma Res., 28, 211, 10.1097/CMR.0000000000000441
10.1080/2162402X.2017.1319044
10.1016/j.tranon.2016.12.002
10.1016/j.ijpharm.2019.05.039
10.1016/j.vaccine.2007.11.020
10.1186/s12885‐017‐3859‐3
10.1158/1078‐0432.CCR‐16‐2821
10.1615/CritRevImmunol.v18.i1‐2.110
Chakravarty PK, 1999, Flt3‐ligand administration after radiation therapy prolongs survival in a murine model of metastatic lung cancer, Cancer Res., 59, 6028
10.1038/s41563‐018‐0028‐2
SomaiahN et al.First‐in‐class first‐in‐human study evaluating LV305 a dendritic‐cell tropic lentiviral vector in sarcoma and other solid tumors expressing NY‐ESO‐1.Clin Cancer Res.2019;10.1158/1078‐0432.CCR‐19‐102531227504
10.1007/s00262‐018‐2287‐9
10.1016/S1567‐5769(02)00251‐5
10.1080/2162402X.2017.1417721
10.1016/j.canlet.2013.03.010
